Publications

Recent publications from the Implementation Science in Aging Research Lab include:

  1. Oche O, Murry LT, Kennelty KA, Keller MS, Pevnick JM, Schnipper JL, Nguyen AL, Ko EM. Pharmacist, Nurse, and Physician Perspectives on the Implementation of the Pharmacist Discharge Care (PHARM-DC) Intervention: A Qualitative Study. Research in Social and Administrative Pharmacy (RSAP). In press. https://doi.org/10.1016/j.sapharm.2024.04.009.
  2. Le TM, Campbell S, Andraos A, Ahlmark P, Hoang H, Isserman S, Goldzweig CL, Mays AM, Bradley K, Keller MS. Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre/post-observational study with a control group. BMJ Open. 2024 Apr 3;14(4):e080109. doi: 10.1136/bmjopen-2023-080109. PMID: 38569687.
  3. Ge Y, Xu S, Hlavka JP, Keller MS, Capron A. Exploring the Impact of COVID-19 Restrictions on Nursing Home Residents, Families, and Staff Perceptions of Bioethical Principles: A Qualitative Study. Journal of Applied Gerontology. In press.
  4. Keller MS, Qureshi N, Mays AM, Sarkisian CA, Pevnick JM. Cumulative Update of a Systematic Overview Evaluating Interventions Addressing Polypharmacy. JAMA Network Open. 2024 Jan 2;7(1):e2350963-.
  5. Silva Almodovar A, Keller MS, Lee V, Mehta HB, Manja V, Phen P, Pavon J, Steinman M, Hoyle D, Mixon AS, Linsky A. Deprescribing medications among patients with multiple prescribers: A socioecological model. J Am Geriatr Soc. 2023; 1-10. doi:10.1111/jgs.18667.
  6. Qureshi N, Keller MS. Identifying Implementation Factors for the Development, Operation, and Sustainment of Ambulatory Care Pharmacy Programs: a Qualitative Study. J Gen Intern Med. 2023 Aug 24. doi: 10.1007/s11606-023-08375-1. Epub ahead of print. PMID: 37620719.
  7. Keller MS, Mavilian C, Altom KL, Erickson KF, Drudi LM, Woo K. Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline. Journal of General Internal Medicine. 2023 Jul 5:1-1.
  8. Morse B, Kim KK, Xu Z, Matsumoto CG, Schilling LM, Ohno-Machado L, Mak SS, Keller MS. Patient and researcher stakeholder preferences for use of electronic health record data: a qualitative study to guide the design and development of a platform to honor patient preferences. Journal of the American Medical Informatics Association. 2023 May 4:ocad058.
  9. Keller MS, Carrascoza-Bolanos J, Breda K, Kim LY, Kennelty KA, Leang D, Murry LT, Nuckols TK, Schnipper J, Pevnick JM. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study. BMJ Open 2023;13:e066234. doi: 10.1136/bmjopen-2022-066234.
  10. Hartzell SY, Keller MS, Albertson EM, Liu Y, Larson M, Friedman S. Variation in Nevada primary care clinicians’ use of urine drug testing to mitigate opioid harm. Journal of Substance Use and Addiction Treatment. 2023 Jan 7:208940.
  11. Nguyen AT, Wisniewski J, Leang DW, Keller MS, Rosen S, Shane R, Pevnick JM. Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions A quasi-experimental controlled study. J Manag Care Spec Pharm. 2023 Mar;29(3)266-275. doi 10.18553jmcp.2023.29.3.266. PMID 36840959.
  12. Keller MS, Carrascoza-Bolanos J. Pharmacists, nurses, and physicians’ perspectives and use of formal and informal interpreters during medication management in the inpatient setting. Patient Educ Couns. 2022 Dec 16:107607. doi: 10.1016/j.pec.2022.107607. Epub ahead of print. PMID: 36566119.
  13. Gregorian T, Bradley K, Campbell S, Mashburn R, Beuttler R, Keller MS. Design, implementation, and evaluation of a pharmacist-led outpatient benzodiazepine-tapering clinic. J Am Pharm Assoc (2003). 2022 Oct 4:S1544-3191(22)00326-0. doi: 10.1016/j.japh.2022.09.025. Epub ahead of print. PMID: 36564330.
  14. Breda K, Keller MS, Gotanda H, Beland A, McKelvey K, Lin C, Rosen S. Geriatric fracture program centering age-friendly care associated with lower length of stay and lower direct costs. Health Serv Res. 2022 Aug 20. doi: 10.1111/1475-6773.14052. Epub ahead of print. PMID: 36054014.
  15. Keller MS, Vordenberg SE, Steinman MA. Moving Deprescribing Upstream. Journal of General Internal Medicine. 2022 Apr 11:1-2.
  16. Murry LT, Keller MS, Pevnick JM, Schnipper JL, Kennelty KA. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework. BMC Health Services Research. 2022 Dec;22(1):1-5.
  17. Thompson AR, Kim CS, Kim GE, Keller MS, Marcum ZA, Brandt NJ. Challenges and Successes of Global Deprescribing Networks: A Qualitative Key Informant Study. Journal of Gerontological Nursing. 2022 Jan 1;48(1):7-14.
  18. SooHoo S, Keller MS, Moyse H, Robbins B, McLaughlin M, Arora A, Burger A, Huang L, Huang SC, Goud A, Truong L. Accessing Patient Electronic Health Record Portals Safely Using Social Credentials: Demonstration Pilot Study. JMIR Formative Research. 2022 Jan 27;6(1):e29647.
  19. Pevnick JM, Keller MS, Kennelty KA, Nuckols TK, Ko M, Amer K, Anderson L, Armbruster C, Conti N, Fanikos J, Guan JF, Knight E, Leang DW, Llamas-Sandoval R, Matta L, Moriarty D, Murry LT, Muske AM, Nguyen AT, Phung E, Rosen O, Rosen SL, Salandanan A, Shane R, Schnipper JL. The Pharmacist Discharge Care (PHARM-DC) Study: A Multicenter RCT of Pharmacist-Directed Transitional Care to Reduce Post-Hospitalization Utilization. Contemporary Clinical Trials. 2021 Apr 28:106419.
  20. Joglekar N, Patel Y, Keller MS. Performance of Inpatient and Outpatient Clinical Decision Support Alerts to Reduce Benzodiazepines and Sedative-Hypnotic Prescribing in Older Adults. Applied Clinical Informatics. 2021 May;12(03):436-44.
  21. Keller MS, Jusufagic A, Nuckols TK, Needleman J, Heilemann M. How do clinicians of different specialties perceive and use opioid risk mitigation strategies? A qualitative study. Accepted for publication, Substance Use and Misuse. 2021. https://doi.org/10.1080/10826084.2021.1926514.
  22. Keller MS, Kiefer E, Campbell S, Bradley K, Mashburn R, Bawa M, Goldzweig C. Sustained Increase of Sedative-Hypnotic Prescribing During the COVID-19 Pandemic in a Large Urban Health System: an Observational Study. Journal of General Internal Medicine. 2021 May 13:1-3.
  23. Lee D, Keller MS, Fridman R, Lee J, Pevnick JM. Association Between Operational Positive Depression Symptom Screen Scores on Hospital Admission and 30-Day Readmissions. Gen Hosp Psychiatry. 2021 Feb 8;70:38-43. doi: 10.1016/j.genhosppsych.2021.02.003. Epub ahead of print. PMID: 33713863.
  24. Keller MS, Truong L, Moser AM, Needleman J, Heilemann MV, Nuckols TK. How do contraindications to non-opioid analgesics and opioids affect the likelihood that patients with back pain diagnoses in the primary care setting receive an opioid prescription? An observational cross-sectional study. BMC Family Medicine. (2021) 22:41.
  25. Keller MS, Chen X, Godwin J, Needleman J, Pourat N. Evaluating inpatient adverse outcomes under California’s Delivery System Reform Incentive Program. Health Services Research. 2020;00:1-13.